Final answer:
A client receiving alteplase for an acute myocardial infarction is likely also to be receiving supplemental oxygen, aspirin, nitroglycerine, and potentially heparin or undergoing procedures like angioplasty, stent insertion, or bypass surgery. Dual antiplatelet therapy may also be prescribed.
Step-by-step explanation:
A nurse reviewing the medication record of a client receiving alteplase after an acute myocardial infarction (MI) should expect to see several additional medications. These typically include supplemental oxygen, aspirin, and nitroglycerine as immediate treatments. Aspirin acts to break up clots, while nitroglycerine, administered sublingually, helps to facilitate absorption due to its vasodilating effect.
Long-term treatments often include the anticoagulant heparin, and in cases of extensive damage, more invasive procedures like balloon angioplasty, stents, or bypass surgery might be necessary. Additionally, dual antiplatelet therapy (DAPT), such as clopidogrel in combination with aspirin, may be prescribed to reduce the risk of further cardiovascular events.
Antiplatelet therapy: Such as clopidogrel or aspirin, which help prevent blood clots and reduce the risk of further MI.
Anticoagulants: Such as heparin, which help prevent the formation or enlargement of blood clots.
Pain medications: Such as opioids or nonsteroidal anti-inflammatory drugs (NSAIDs), to manage chest pain or discomfort associated with the MI.